期刊
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
卷 41, 期 16, 页码 7949-7965出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2022.2127903
关键词
SARS-CoV-2; COVID-19; docking; nsps; ORFs; drug repurposing
SARS-CoV-2, the novel coronavirus, has prompted the urgent need for repurposing drugs to combat the global pandemic. In this study, molecular docking was used to evaluate the potential inhibitory effects of five FDA approved repurposed drugs against SARS-CoV-2 proteins. Umifenovir and Pregnenolone showed potential as inhibitors for most of the proteins. These drugs should be further studied in vitro and in vivo due to their high binding affinity. Communicated by Ramaswamy H. Sarma.
SARS-CoV-2, the novel coronavirus spreading worldwide urges the need to repurpose drugs that can quickly enter clinical trials to combat the on-going global pandemic. A cluster of proteins are encoded for by the viral genome, each assuming a critical role in pathogen endurance inside the host. To handle the adverse circumstances, robust virtual strategies such as repurposing are coming to the fore due to being economical, efficient and rapid. Five FDA approved repurposed drugs proposed to act as inhibitors by targeting SARS-CoV-2 were used for initial evaluation via molecular docking. Moreover, a comparative analysis of the selected SARS-CoV-2 proteins against five ligands (Clemizole hydrochloride, Exemestane, Nafamostat, Pregnenolone and Umifenovir) was designed. In this regard, non-structural proteins (nsp3, nsp5, nsp10, nsp12 and nsp15), structural proteins (Spike, Nucleocapsid protein) and accessory proteins (ORF 3a, ORF 7a and ORF 9 b) were selected. Here, we aim to expedite the search for a potential drug from the five FDA approved repurposing drugs already in use for treatment of multiple diseases. Based on docking analysis, Umifenovir and Pregnenolone are suggested to show potential inhibitory effects against most of the SARS-CoV-2 proteins. These drugs are noteworthy since they exhibit high binding towards target proteins and should be used as lead compounds towards in vitro and in vivo studies. Communicated by Ramaswamy H. Sarma
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据